Compare Stocks: ELMD, BBNX, INMD, and SIBN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$19.42 -2.5%	$17.17	$8.80 ▼ $32.71	$896.20M	3.37	1.03 million shs	1.41 million shs
ELMD Electromed	$28.00 +1.4%	$39.91	$23.01 ▼ $47.40	$234.25M	0.46	77,068 shs	118,107 shs
INMD InMode	$14.91 +0.5%	$15.06	$12.72 ▼ $16.74	$853.02M	1.86	433,998 shs	213,084 shs
SIBN SiBone	$18.50 -0.8%	$18.12	$11.48 ▼ $21.89	$826.67M	0.7	510,145 shs	389,529 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	-2.51%	-1.52%	+39.61%	+39.81%	-1.32%
ELMD Electromed	+1.41%	-5.41%	-33.13%	-25.71%	+17.45%
INMD InMode	+0.47%	+0.40%	-1.97%	+10.12%	+2.76%
SIBN SiBone	-0.75%	-3.70%	+2.55%	+22.35%	+14.06%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$19.42 -2.5%	$17.17	$8.80 ▼ $32.71	$896.20M	3.37	1.03 million shs	1.41 million shs
ELMD Electromed	$28.00 +1.4%	$39.91	$23.01 ▼ $47.40	$234.25M	0.46	77,068 shs	118,107 shs
INMD InMode	$14.91 +0.5%	$15.06	$12.72 ▼ $16.74	$853.02M	1.86	433,998 shs	213,084 shs
SIBN SiBone	$18.50 -0.8%	$18.12	$11.48 ▼ $21.89	$826.67M	0.7	510,145 shs	389,529 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	-2.51%	-1.52%	+39.61%	+39.81%	-1.32%
ELMD Electromed	+1.41%	-5.41%	-33.13%	-25.71%	+17.45%
INMD InMode	+0.47%	+0.40%	-1.97%	+10.12%	+2.76%
SIBN SiBone	-0.75%	-3.70%	+2.55%	+22.35%	+14.06%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.50	Moderate Buy	$20.10	3.50% Upside
ELMD Electromed	2.75	Moderate Buy	$43.75	56.25% Upside
INMD InMode	2.00	Hold	$16.00	7.31% Upside
SIBN SiBone	2.71	Moderate Buy	$24.17	30.63% Upside

Current Analyst Ratings Breakdown

Latest ELMD, BBNX, INMD, and SIBN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/26/2026	ELMD Electromed	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$50.00
8/26/2026	ELMD Electromed	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$36.00 ➝ $47.00
8/21/2026	BBNX Beta Bionics	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Market Perform
8/20/2026	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/18/2026	BBNX Beta Bionics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/6/2026	INMD InMode	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/5/2026	SIBN SiBone	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/4/2026	SIBN SiBone	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$24.00 ➝ $25.00
8/4/2026	SIBN SiBone	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$18.00 ➝ $20.00
8/4/2026	SIBN SiBone	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$21.00 ➝ $23.00
7/28/2026	SIBN SiBone	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$24.00

(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$100.25M	8.72	N/A	N/A	$5.70 per share	3.41
ELMD Electromed	$73.78M	3.18	$0.68 per share	41.36	$5.10 per share	5.49
INMD InMode	$370.49M	2.31	$1.50 per share	9.95	$10.94 per share	1.36
SIBN SiBone	$213.60M	3.84	N/A	N/A	$4.11 per share	4.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	-$73.20M	-$1.65	N/A	N/A	N/A	-61.31%	-26.30%	-23.25%	N/A
ELMD Electromed	$5.15M	$1.31	37.33	N/A	N/A	11.34%	15.71%	13.37%	N/A
INMD InMode	$93.83M	$1.23	12.12	N/A	N/A	20.69%	11.99%	10.60%	10/28/2026 (Estimated)
SIBN SiBone	-$18.90M	-$0.34	N/A	N/A	N/A	-6.85%	-8.23%	-6.07%	11/9/2026 (Estimated)

Latest ELMD, BBNX, INMD, and SIBN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	INMD InMode	$0.3460	$0.35	+$0.0040	$0.29	$94.89 million	$95.59 million
8/3/2026	Q2 2026	SIBN SiBone	-$0.1495	-$0.09	+$0.0595	-$0.09	$55.34 million	$56.01 million
7/29/2026	Q2 2026	BBNX Beta Bionics	-$0.62	-$0.53	+$0.09	-$0.53	N/A	$32.01 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
SIBN SiBone	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	8.88	7.96
ELMD Electromed	N/A	5.10	4.74
INMD InMode	N/A	8.18	7.28
SIBN SiBone	0.20	9.15	7.55

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
ELMD Electromed	40.82%
INMD InMode	68.04%
SIBN SiBone	98.11%

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	5.30%
ELMD Electromed	10.50%
INMD InMode	6.92%
SIBN SiBone	4.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	44.99 million	42.61 million	N/A
ELMD Electromed	160	8.37 million	7.36 million	Optionable
INMD InMode	480	57.48 million	53.50 million	Optionable
SIBN SiBone	350	44.35 million	42.58 million	Optionable

ELMD, BBNX, INMD, and SIBN Headlines

Recent News About These Companies

SiBone (NASDAQ:SIBN) Director Sells 20,000 Shares of Stock

September 4 at 6:51 AM | insidertrades.com

SiBone (NASDAQ:SIBN) Director Jeffrey Dunn Sells 20,000 Shares of Stock

September 3 at 9:12 PM | marketbeat.com

SiBone (NASDAQ:SIBN) Given Average Recommendation of "Moderate Buy" by Brokerages

September 3 at 2:46 AM | americanbankingnews.com

SiBone (NASDAQ:SIBN) Receives Average Recommendation of "Moderate Buy" from Brokerages

September 3 at 2:13 AM | marketbeat.com

SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026

August 31, 2026 | globenewswire.com

Anshul Maheshwari Sells 11,636 Shares of SiBone (NASDAQ:SIBN) Stock

August 27, 2026 | insidertrades.com

SiBone (NASDAQ:SIBN) Insider Anshul Maheshwari Sells 11,636 Shares of Stock

August 26, 2026 | marketbeat.com

SiBone (NASDAQ:SIBN) CEO Sells $522,556.64 in Stock

August 26, 2026 | marketbeat.com

Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?

August 25, 2026 | zacks.com

Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade

August 24, 2026 | zacks.com

SiBone (NASDAQ:SIBN) CEO Sells 3,923 Shares of Stock

August 22, 2026 | insidertrades.com

Insider Selling: SiBone (NASDAQ:SIBN) CEO Sells 3,923 Shares of Stock

August 21, 2026 | marketbeat.com

SiBone (NASDAQ:SIBN) Insider Sells $112,353.85 in Stock

August 21, 2026 | marketbeat.com

Anshul Maheshwari Sells 11,228 Shares of SiBone (NASDAQ:SIBN) Stock

August 21, 2026 | marketbeat.com

SiBone (NASDAQ:SIBN) CEO Laura Francis Sells 51,884 Shares of Stock

August 21, 2026 | marketbeat.com

Michael Pisetsky Sells 3,725 Shares of SiBone (NASDAQ:SIBN) Stock

August 19, 2026 | insidertrades.com

SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,725 Shares of Stock

August 18, 2026 | marketbeat.com

Anshul Maheshwari Sells 4,665 Shares of SiBone (NASDAQ:SIBN) Stock

August 18, 2026 | marketbeat.com

SiBone $SIBN Shares Bought by Dimensional Fund Advisors LP

August 11, 2026 | marketbeat.com

SiBone (NASDAQ:SIBN) Receives Consensus Rating of "Moderate Buy" from Analysts

August 9, 2026 | marketbeat.com

SiBone $SIBN Shares Purchased by Sei Investments Co.

August 7, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD, BBNX, INMD, and SIBN Company Descriptions

Beta Bionics NASDAQ:BBNX

$19.42 -0.50 (-2.51%)

As of 09/4/2026 04:00 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Electromed NYSE:ELMD

$28.00 +0.39 (+1.41%)

As of 09/4/2026 04:00 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

InMode NASDAQ:INMD

$14.91 +0.07 (+0.47%)

As of 09/4/2026 04:00 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

SiBone NASDAQ:SIBN

$18.50 -0.14 (-0.75%)

As of 09/4/2026 04:00 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ELMD, BBNX, INMD, and SIBN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ELMD, BBNX, INMD, and SIBN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ELMD, BBNX, INMD, and SIBN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD, BBNX, INMD, and SIBN Company Descriptions

Beta Bionics NASDAQ:BBNX

Electromed NYSE:ELMD

InMode NASDAQ:INMD

SiBone NASDAQ:SIBN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ELMD, BBNX, INMD, and SIBN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ELMD, BBNX, INMD, and SIBN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ELMD, BBNX, INMD, and SIBN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD, BBNX, INMD, and SIBN Company Descriptions

Beta Bionics NASDAQ:BBNX

Electromed NYSE:ELMD

InMode NASDAQ:INMD

SiBone NASDAQ:SIBN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools